The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
The evaluation of chronic obstructive pulmonary diseases by gender in Turkey: incidence, prevalence, and mortality
Aims: The aim of this study was to evaluate the incidence and prevalence of chronic obstructive pulmonary disease (COPD) and COPD-related deaths by gender in Turkey.
Methods: The data used in the study, covering the years 1990-2019, were taken from the estimation data prepared for Turkey within the global burden of disease study by the Institute for Health Metrics and Evaluation (IHME). Mann-Whitney test was applied to compare the variables according to gender. Non-parametric Spearman rank correlation coefficient was calculated to determine the relationships between variables.
Results: The difference between the mean ranks of the total number of prevalences, the total number of incidences, and the total number of deaths by gender were statistically significant. A strong and linear association was found between the risk factors and deaths due to COPD.
Conclusion: Policies are needed to decrease the risk factors that lead to the development of COPD. The more risk factors can be controlled, the more lives can be saved.

1. Gözlü K. Sağlığın sosyal bir belirleyicisi: sağlık okuryazarlığı. SDÜ TıpFakültesi Derg. 2021;27(1):137-144. doi:10.17343/sdutfd.569301
2. Bush A. Lung development and aging. Ann Am Thorac Soc. 2016;13Suppl 5:S438-s446. doi:10.1513/AnnalsATS.201602-112AW
3. Zhou Y, Chen R. Risk factors and intervention for chronic obstructivepulmonary disease in China. Respirology. 2013;18:4-9. doi:10.1111/resp.12190
4. Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into chronic obstructive pulmonarydisease as critical risk factor for cardiovascular disease. Int J ChronicObstructive Pulmonary Dis. 2020;15:755-764.doi:10.2147/copd.s238214
5. Sharma G, Goodwin J. Effect of aging on respiratory system physiologyand immunology. Clin Interv Aging. 2006;1(3):253-60. doi:10.2147/ciia.2006.1.3.253
6. WHO. The top 10 causes of death. Accessed 29.01, 2023.
7. WHO. Chronic obstructive pulmonary disease (COPD). WHO.Accessed 28.01, 2023.
8. WHO. Top 10 causes of death in Türkiye for both sexes aged all ages.Accessed 29.01, 2023.
9. Demir A, Büyükşirin M, Polat G, et al. KOAH çadırında ölçülen SFTsonuçları ve KOAH risk faktörlerinin değerlendirilmesi. Toraks Dergisi.2006;7(1):23-28.
10. Eisner MD, Anthonisen N, Coultas D, et al. An official AmericanThoracic Society public policy statement: Novel risk factors and theglobal burden of chronic obstructive pulmonary disease. Am J RespirCrit Care Med. 2010;182(5):693-718. doi:10.1164/rccm.200811-1757ST
11. Salvi S. Tobacco smoking and environmental risk factors for chronicobstructive pulmonary disease. Clin Chest Med. 2014;35(1):17-27.doi:10.1016/j.ccm.2013.09.011
12. Antó JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronicobstructive pulmonary disease. Eur Respir J. 2001;17(5):982-994. doi:10.1183/09031936.01.17509820
13. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLDScientific Committee. Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD)Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276. doi:10.1164/ajrccm.163.5.2101039
14. GBD. Global Burden of Disease Collaborative Network. Global Burdenof Disease Study 2019 (GBD 2019) Results.Seattle, United States:Institute for Health Metrics and Evaluation (IHME), 2020. Availablefrom Accessed 26.012023.
15. Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonarydisease: the impact of gender. Curr Opin Pulm Med. 2017;23(2):117-123.doi:10.1097/MCP.0000000000000353
16. Han MK. Chronic obstructive pulmonary disease in women: abiologically focused review with a systematic search strategy. Int JChron Obstruct Pulmon Dis. 2020;15:711-721. doi: 10.2147/COPD.S237228
17. Kirkpatrick dP, Dransfield MT. Racial and sex differences in chronicobstructive pulmonary disease susceptibility, diagnosis, and treatment.Curr Opin Pulmonary Med. 2009;15(2):100-104. doi: 10.1097/MCP.0b013e3283232825
18. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé-Illa F. Factoresasociados a la mortalidad global en los pacientes diagnosticadosde enfermedad pulmonar obstructiva crónica. Aten Primaria.2015;47(8):498-504. doi:10.1016/j.aprim.2014.11.004
19. Seo JY, Hwang YI, Mun SY, et al. Awareness of COPD in a high riskKorean population. Yonsei Med J. 2015;56(2):362-367. doi:10.3349/ymj.2015.56.2.362
20. Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronicobstructive pulmonary disease risk and treatment outcomes. Int JChron Obstruct Pulmon Dis. 2014;9:1145-1154. doi:10.2147/COPD.S54476
Volume 1, Issue 1, 2023
Page : 5-8